CFAP43 variant in persistent respiratory symptoms after hematopoietic cell transplantation
2024
CFAP43 Variant and Respiratory Symptoms After Transplant
Sample size: 1
publication
Evidence: low
Author Information
Author(s): Nagasawa Shun, Nishimura Toyoki, Yamada Ai, Kamimura Sachiyo, Ishimura Masataka, Moritake Hiroshi
Primary Institution: University of Miyazaki
Hypothesis
The heterozygous CFAP43 variant might impair ciliary function and cause persistent respiratory symptoms after HCT.
Conclusion
Heterozygous CFAP43 nonsense variants may lead to persistent respiratory symptoms after HCT.
Supporting Evidence
- The patient developed pneumonia, sinusitis, and otitis media after hematopoietic cell transplantation.
- A heterozygous CFAP43 nonsense variant was identified in the patient.
- Immunosuppressive therapy was discontinued 20 months after HCT.
- The patient experienced recurrent respiratory symptoms for 7 years.
Takeaway
A girl had breathing problems after a medical procedure, and doctors found a gene change that might be causing her issues.
Methodology
Whole-exome sequencing was used to identify the CFAP43 variant in the patient.
Limitations
Transmission electron microscopy did not reveal abnormal ciliary ultrastructures during recovery.
Participant Demographics
An 18-month-old Japanese girl.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website